- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03991026
Healthy Foods and Education to Treat Diabetes
8. november 2019 oppdatert av: Johns Hopkins University
Farm to Clinic Vegetable Initiative at East Baltimore Medical Center
The investigators will study a program that delivers weekly community-supported agriculture shares to patients of East Baltimore Medical Center in order to increase access to healthy foods.
The investigators will provide adult patients with uncontrolled diabetes with healthy foods including fresh vegetables and shelf-stable pantry items (e.g., canned beans) every week over the course of 6 weeks.
The investigators will also collect demographic data and food insecurity status of participants via survey.
This program will also conduct weekly cooking and nutrition classes at East Baltimore Medical Center.
The investigators will conduct a survey of participants' experiences each time participants pick up a vegetable bag and at the end of the cooking classes.
In addition, a focus group of participants will be held to gather qualitative data regarding the vegetable initiative.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Faktiske)
29
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Maryland
-
Baltimore, Maryland, Forente stater, 21202
- Johns Hopkins Community Physicians at East Baltimore Medical Center
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Patients with uncontrolled diabetes mellitus (defined as a glycosylated hemoglobin >8%)
- 18 years age of and over
- Living within the geographical region of East Baltimore Medical Campus
Exclusion Criteria:
- Current participation in Five Plus Nuts and Beans Study or other program that provides diet-based food
- Non-English speaking
- On hospice or palliative care
- Acute or chronic psychosis
- Active substance or alcohol use disorder
- Another active medical disorder that would preclude participation in weekly food pick-up or classes including: active treatment of cancer, steroid dependent asthma/chronic obstructive pulmonary disease/emphysema, steroid dependent colitis; chronic kidney disease with an estimated glomerular filtration rate less than 30mg/mmol, venous thromboembolic disease with current treatment with vitamin K antagonist, Celiac disease, cirrhosis or steroid dependent arthritis
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Healthy food and Education/Cooking Classes
At consent, participant will complete the baseline survey.
Baseline survey will collect information like vegetable consumption, healthy eating attitudes, and demographics.
Every week for 6 weeks, participants will pick-up a healthy food bag (e.g.
fresh vegetables) for a $3 co-pay and attend an hour-long education classes at East Baltimore Medical Center.
All participants will complete a survey at healthy food bag pick-up or an education class.
Surveys at bag pick-up will ascertain outcomes like vegetable consumption.
Surveys at education classes will ascertain outcomes like healthy eating attitudes.
At 6 weeks, all participants will complete a follow-up survey equivalent to the baseline survey.
The follow-up survey will be completed again at 10 weeks, 18 weeks, and 30 weeks.
Participants will also be weighed at each bag pick-up (participants may decline) and relevant health information like blood pressure will be obtained from the EMR from an associated office visit.
|
The intervention includes providing weekly seasonal produce and healthy foods to participants in addition to an education/cooking class that will be tailored to Diabetes Mellitus, Type II.
|
|
Ingen inngripen: Control Group
At consent, participant will complete the baseline survey.
Baseline survey will collect information like vegetable consumption, cooking habits, food security, healthy eating attitudes, and demographics.
As a control group, participants will not partake in the healthy food bag pick-ups or cooking classes therefore they will not fill out those associated surveys.
After the 6 weeks of the intervention, control participants will be given the follow-up survey equivalent to the baseline survey.
The follow-up survey will be completed again after 10 weeks, 18 weeks, and 30 weeks.
Participants will also be weighed at each bag pick-up (participants may decline) and relevant health information like blood pressure will be obtained from the EMR from an associated office visit.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in amount of vegetables eaten
Tidsramme: Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
Self-reported number of vegetables eaten per day (e.g. 2 vegetables/day) will be obtained by the survey.
|
Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
|
Change in weight (kg)
Tidsramme: Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
Recorded from Electronic Medical Record (EMR) or weighed at weekly bag pick-up.
|
Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
|
Change in Body mass index (kg/m^2)
Tidsramme: Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
Recorded from EMR or calculated with height of record.
|
Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Glycosylated Hemoglobin level (percent of mmol/mol)
Tidsramme: Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
Recorded from EMR.
|
Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
|
Change in Blood pressure (mmHg)
Tidsramme: Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
Recorded from EMR.
|
Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Donald RB Miles, MD, Johns Hopkins Community Physicians
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
18. juni 2019
Primær fullføring (Faktiske)
26. september 2019
Studiet fullført (Faktiske)
26. september 2019
Datoer for studieregistrering
Først innsendt
18. juni 2019
Først innsendt som oppfylte QC-kriteriene
18. juni 2019
Først lagt ut (Faktiske)
19. juni 2019
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
12. november 2019
Siste oppdatering sendt inn som oppfylte QC-kriteriene
8. november 2019
Sist bekreftet
1. november 2019
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- IRB00164545
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Nei
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Sukkersyke
-
State University of New York at BuffaloMedical University of South CarolinaFullførtSukkersyke | Type 2 diabetes mellitus | Voksendiabetes mellitus | Ikke-insulinavhengig diabetes mellitus | Ikke-insulinavhengig diabetes mellitus, type IIForente stater
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.FullførtDiabetes mellitus, type 1 | Type 1 diabetes | Diabetes type 1 | Type 1 diabetes mellitus | Autoimmun diabetes | Diabetes mellitus, insulinavhengig | Juvenil-Debut Diabetes | Diabetes, autoimmun | Insulinavhengig diabetes mellitus 1 | Diabetes mellitus, insulinavhengig, 1 | Diabetes mellitus, sprø | Diabetes mellitus... og andre forholdForente stater
-
Superior UniversityAktiv, ikke rekrutterendeType 2 diabetes mellitus 1Pakistan
-
Meir Medical CenterFullførtDiabetes mellitus type 2 | Diabetes mellitus, ikke-insulinavhengig | Diabetes mellitus, om oral hypoglykemisk behandling | Voksen type diabetes mellitusIsrael
-
Peking Union Medical College HospitalUkjentType 2 diabetes mellitus | Type 1 diabetes mellitus | Svangerskapsdiabetes mellitus | Pankreatogen diabetes mellitus | Pregestasjonell diabetes mellitus | Diabetespasienter i perioperativ periodeKina
-
Guang NingRekrutteringType 2 diabetes mellitus | Type 1 diabetes mellitus | Monogenetisk diabetes | Pankreatogen diabetes | Legemiddelindusert diabetes mellitus | Andre former for diabetes mellitusKina
-
SanofiFullførtType 1 Diabetes Mellitus-Type 2 Diabetes MellitusUngarn, Den russiske føderasjonen, Tyskland, Polen, Japan, Forente stater, Finland
-
Hoffmann-La RocheRoche DiagnosticsFullførtDiabetes mellitus type 2, diabetes mellitus type 1Tyskland
-
University of California, San FranciscoJuvenile Diabetes Research FoundationFullførtType 1 diabetes mellitus | Diabetes mellitus, type I | Insulinavhengig diabetes mellitus 1 | Diabetes mellitus, insulinavhengig, 1 | IDDMForente stater, Australia
-
Vanderbilt University Medical CenterRekrutteringHyperglykemi | Type 2 diabetes mellitus (T2DM) | Type 1 diabetes mellitus (T1DM)Forente stater